Clinical Support Services for the NIAMS Intramural Research Program

$11,622,016ZIDFY2023ARNIH

National Institute Of Arthritis And Musculoskeletal And Skin Diseases

Investigators

Linked publications & trials

Paper 35793467 Paper 35792044 Paper 35762866 Paper 35485412 Paper 35257507 Paper 35257501 Paper 35189151 Paper 34611997 Paper 33950229 Paper 33779074 Paper 33731872 Paper 33455077 Paper 32889531 Paper 32843325 Paper 32791068 Paper 32657971 Paper 32524767 Paper 32359360 Paper 32249511 Paper 32232430 Paper 31015188 Paper 30138550 Paper 30131320 Paper 30122538 Paper 30031493 Paper 30028529 Paper 30005854 Paper 30001792 Paper 30001781 Paper 29999544 Paper 29997110 Paper 29963054 Paper 29878063 Paper 29728522 Paper 29724730 Paper 29717110 Paper 29669944 Paper 29666047 Paper 29649002 Paper 29643386 Paper 29609200 Paper 29606667 Paper 29588275 Paper 29582188 Paper 29575810 Paper 29538758 Paper 29538011 Paper 29484197 Paper 29480216 Paper 29436480 Paper 29427642 Paper 29346706 Paper 29298709 Paper 29292104 Paper 29245173 Paper 29221629 Paper 29196457 Paper 29177080 Paper 29145713 Paper 29121457 Paper 29106061 Paper 29079590 Paper 29045217 Paper 28993780 Paper 28966206 Paper 28832350 Paper 28780639 Paper 28639951 Paper 28544766 Paper 28544690 Paper 28507186 Paper 28444299 Paper 28389987 Paper 28385805 Paper 28382787 Paper 28379475 Paper 28335798 Paper 28263189 Paper 28255960 Paper 28194438 Paper 28188227 Paper 28179497 Paper 28148752 Paper 28096072 Paper 28085235 Paper 28066895 Paper 28008916 Paper 27895041 Paper 27886701 Paper 27886695 Paper 27696779 Paper 27543414 Paper 27507156 Paper 27435189 Paper 27432938 Paper 27429362 Paper 27273981 Paper 27241241 Paper 27227346 Paper 27159737

Abstract

This project has provided research infrastructure support for FY23 for the clinical protocols listed below. These protocols serve a variety of research needs for investigators in the NIAMS. 03-AR-0173: Studies of the Natural History, Pathogenesis and Outcome in Autoimmune and Inflammatory Diseases Including Juvenile Dermatomyositis 11-AR-0223: Studies on the Natural History and Pathogenesis of Spondyloarthritis 12-AR-8001: Compassionate Use Treatment Protocol 14V-MC-JAGA Treatment of Autoinflammatory Syndromes Expected to Benefit from JAK 1/2 Inhibition 18-AR-0081: Investigation of the Natural History, Genetics and Pathophysiology of Systemic Juvenile Idiopathic Arthritis and Adult-onset Still's Disease and Related Inflammatory Conditions 91-AR-0196: Studies on the Natural History and Pathogenesis of Polymyositis, Dermatomyositis, and Related Diseases 01-AR-0227: Natural History of Rheumatic Disease in Minority Communities 14-AR-0200: Studies of the Natural History, Pathogenesis and Outcome of Idiopathic Systemic Vasculitis 15-AR-0165: Study of the Natural History, Pathogenesis and Outcome of Melorheostosis-a Rare Osteosclerotic Disease 03-AR-0131: Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study 04-AR-0205: Progression of Spinal Fusion in Ankylosing Spondylitis 15-AR-0060: The Role of PPAR-gamma Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE) 94-AR-0066: Studies of the Pathogenesis and Natural History of Systemic Lupus Erythematosus (SLE) 13-AR-0056: Stopping Anti-TNF Agents in Rheumatoid Arthritis (STARA) Trial 15-AR-N010: Frequency and Complications of Major Orthopedic Procedures in Medicare Beneficiaries 96-AR-0102: Standard Care Dermatology; Evaluation and treatment of subjects with dermatologic diseases 000207: SAD-COVID: The natural history of coronavirus disease (COVID-19) in systemic autoimmune diseases; an observational prospective study 20-AR-0032: Glucocorticoid Genomics in SLE; Genomic effects of glucocorticoids in patients with systemic lupus erythematosus 13-AR-0005: STOP LUPUS: A phase 1b, randomized, double-blind, placebo controlled study with an open label extension to evaluate the safety and tolerability of Omalizumab, a humanized IgG1 monoclonal antibody in patients with lupus (STOP LUPUS)

View original record on NIH RePORTER →